predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer

Multigene assays have been developed and validated to determine the prognosis of breast cancer. In this study, we assessed the additional predictive value of the 70-gene MammaPrint signature for chemotherapy (CT) benefit in addition to endocrine therapy (ET) from pooled study series. For 541 patient...

Full description

Saved in:
Bibliographic Details
Published in:Breast cancer research and treatment Vol. 120; no. 3; pp. 655 - 661
Main Authors: Knauer, Michael, Mook, Stella, Rutgers, Emiel J. T, Bender, Richard A, Hauptmann, Michael, van de Vijver, Marc J, Koornstra, Rutger H. T, Bueno-de-Mesquita, Jolien M, Linn, Sabine C, van 't Veer, Laura J
Format: Journal Article
Language:English
Published: Boston Boston : Springer US 01.04.2010
Springer US
Springer
Springer Nature B.V
Springer Verlag
Subjects:
ISSN:0167-6806, 1573-7217, 1573-7217
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first